Changing the ‘Art’ of Growing Cells into an Industrialized Platform for Commercial-Scale Manufacturing
Published: November 6, 2018Latest Advances in Bioprocessing: Overcoming Bottlenecks
Lior Raviv
For the last few years, the cell therapy industry has evolved from a ‘research’ state of mind to a commercialization focus. The recent approvals for Kite, Novartis and Tigenix have boosted the evolutionary process and changed the focus from ‘how to bring the product to approval?’ to ‘what will happen afterwards?’. Based on the proof that cell therapies do work and hold the potential to change the way medicine is practiced, the cell therapy industry is now mature enough to start facing the gaps in translating the manufacturing lines into industrialized platforms.
DOI: 10.18609/cgti.2018.082Citation: Cell Gene Therapy Insights 2018; 4(8), 805-814.
This content is restricted to registered users. Click here to Register or Login here.
